Romiplostims farmakokinetik involverede target- medieret aflejring, hvilket antageligt medieres af TPO- receptorer på trombocytter og andre celler af trombopoietisk afstamning, såsom megakaryocytter.
The pharmacokinetics of romiplostim involved target-mediated disposition, which is presumably mediated by TPO receptors on platelets and other cells of the thrombopoietic lineage such as megakaryocytes.